EASY BIO Inc. said its second-quarter normalized net income came to 255.19 South Korean won per share, a decline of 35.5% from 395.92 won per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 13.80 billion won, a decline of 24.2% from 18.21 billion won in the year-earlier period.
The normalized profit margin dropped to 4.0% from 4.8% in the year-earlier period.
Total revenue fell on an annual basis to 368.19 billion won from 380.76 billion won, and total operating expenses fell 5.8% from the prior-year period to 334.24 billion won from 354.87 billion won.
Reported net income declined 33.3% from the prior-year period to 12.71 billion won, or 235.00 won per share, from 19.06 billion won, or 414.29 won per share.
As of Aug. 17, US$1 was equivalent to 1,183.06 South Korean won.